News for Healthier Living

Study Identifies Potential Therapeutic Target Protein that Drives Metabolic Liver Disease Independent of Diet

Obesity-related metabolic liver disease affects hundreds of millions of people worldwide. New research found a protein, EFHD1, that drives liver damage by triggering an out-of-place antiviral immune response. Blocking EFHD1 can protect against liver injury in human cells and mouse models.

September 1, 2026


September 8 2026

September 7 2026

September 5 2026

September 4 2026

September 3 2026

September 2 2026

September 1 2026

August 31 2026

August 30 2026

August 29 2026

August 28 2026

August 27 2026

August 26 2026

August 25 2026